Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma

A J Davies, A Z S Rohatiner, S Howell, K E Britton, S E Owens, I N Micallef, D P Deakin, B M Carrington, J A Lawrance, S Vinnicombe, S J Mather, J Clayton, R Foley, H Jan, S Kroll, M Harris, J Amess, A J Norton, T A Lister, J A Radford

    Research output: Contribution to journalArticlepeer-review

    108 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Keyphrases